Viewing Study NCT01648192


Ignite Creation Date: 2025-12-24 @ 3:37 PM
Ignite Modification Date: 2026-02-23 @ 1:10 AM
Study NCT ID: NCT01648192
Status: COMPLETED
Last Update Posted: 2017-07-26
First Post: 2012-07-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of GW856553 (Losmapimod)
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Coronary Syndrome View
Keywords: